Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Germline variants and their role in the pathogenesis of immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) in adult lymphoma patients

Blood (2025) 146 (Supplement 1): 806.

https://doi.org/10.1182/blood-2025-806

Published: 2025

Journal Articles

A Phase II, single-center, single-arm study evaluating the safety and efficacy of golidocitinib in the management of newly diagnosed PTCL (GOLDEN Study)

Eduardo Edelman Saul, Jessie Xu, Casey Bermack, Cathrine Paras, Jared Henderson, Kristofer Jennings, Bryan Valcarcel, Dr. Mohammad Abdul-Jaber Abdulla, Luis Fayad, Hun Lee, Preetesh Jain, Ranjit Nair, Michael Wang, Swami Iyer, Christopher Flowers, Luis Malpica

Blood (2025) 146 (Supplement 1): 5434.

https://doi.org/10.1182/blood-2025-5434

Published: 2025

Journal Articles

Mortality outcomes compared to the general population among long-term Hodgkin lymphoma survivors: A population-based analysis

Bryan Valcarcel, Michelle Hildebrandt, Maria Rodriguez, Sairah Ahmed, Hun Lee, Michael Wang, Preetesh Jain, Ranjit Nair, Swami Iyer, Christopher Flowers, Luis Malpica

Blood (2025) 146 (Supplement 1): 2716.

https://doi.org/10.1182/blood-2025-2716

Published: 2025

Journal Articles

Interim PET-adapted de-escalation chemotherapy regimen for advanced stage classical Hodgkin lymphoma using brentuximab vedotin, pembrolizumab, doxorubicin, and dacarbazine: Phase 2 study

Hun Lee, Gregory Ravizzini, Jenna Wixom, Ayushi Chauhan, Luis Fayad, Ranjit Nair, Jason Westin, Jared Henderson, Eslam Aboismail, Christopher Flowers, Michael Wang, Luis Malpica Castillo

Blood (2025) 146 (Supplement 1): 153.

https://doi.org/10.1182/blood-2025-153

Published: 2025

Journal Articles

Consolidation with loncastuximab tesirine for large B-cell lymphoma patients in partial response after CART: Planned interim futility analysis of a phase II trial

Mark Hamilton, Ajlan Al Zaki, Lei Feng, Zachary Hunzeker, Dai Chihara, Hun Lee, Chitra Hosing, Laura Ebarle, Oluwadare Ajishegiri, Jason Westin, Sairah Ahmed, Sattva Neelapu, Paolo Strati

Blood (2025) 146 (Supplement 1): 5485.

https://doi.org/10.1182/blood-2025-5485

Published: 2025

Journal Articles

Impact of putative cell of origin on CD19+CAR-T outcomes in patients with large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 5500.

https://doi.org/10.1182/blood-2025-5500

Published: 2025

Journal Articles

Impact of extranodal sites of lymphoma on clinical outcomes after CD19 CAR T cell therapy

Blood (2025) 146 (Supplement 1): 1931.

https://doi.org/10.1182/blood-2025-1931

Published: 2025

Journal Articles

Durable responses in the updated 2-year follow-up of patients from a single-center with Relapsed/Refractory peripheral T-cell lymphoma treated with golidocitinib

Blood (2025) 146 (Supplement 1): 5422.

https://doi.org/10.1182/blood-2025-5422

Published: 2025

Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Advanced Stage Classic Hodgkin Lymphoma: Updated Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part B)

Blood (2022) 140 (Supplement 1): 763–765.

https://doi.org/10.1182/blood-2022-156553

Published: 2022

Journal Articles

Analysis of Factors Associated with Conversion to CR in Patients with Large B-Cell Lymphoma Achieving Day 30 PR after CAR T-Cell Therapy

Ajlan Al Zaki, Jason R. Westin, Grace Watson, Lei Feng, Sairah Ahmed, Haleigh Mistry, Loretta Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P Iyer, Hun Lee, Raphael E Steiner, Christopher R. Flowers, Elizabeth J. Shpall, Partow Kebriaei, Sattva S. Neelapu, Paolo Strati

Blood (2021) 138 (Supplement 1): 3870.

https://doi.org/10.1182/blood-2021-146023

Published: 2021

Journal Articles

Single Cell Transcriptomic Evolution and Resistance Mechanisms of BTK and BCL-2 Inhibition in Mantle Cell Lymphoma

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-140882

Published: 2020

Journal Articles

Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-139880

Published: 2020

Journal Articles

Conditional ablation of LYVE-1+ cells unveils defensive roles of lymphatic vessels in intestine and lymph nodes

Jeon Yeob Jang, Young Jun Koh, Seung-Hun Lee, Junyeop Lee, Kyoo Hyun Kim, Daesoo Kim, Gou Young Koh, Ook Joon Yoo

Blood (2013) 122 (13): 2151–2161.

https://doi.org/10.1182/blood-2013-01-478941

Published: 2013

Includes: Supplemental data

Journal Articles

ROCK suppression promotes differentiation and expansion of endothelial cells from embryonic stem cell–derived Flk1 + mesodermal precursor cells

Hyung Joon Joo, Dong-Kyu Choi, Joon Seo Lim, Jin-Sung Park, Seung-Hun Lee, Sukhyun Song, Jennifer H. Shin, Do-Sun Lim, Injune Kim, Ki-Chul Hwang, Gou Young Koh

Blood (2012) 120 (13): 2733–2744.

https://doi.org/10.1182/blood-2012-04-421610

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

Improved Survival in Chronic Myeloid Leukemia (CML) Since the Introductin of Imatinib Therapy - A Single Institution Historical Experience

Hun Lee, MD, Jorge E. Cortes, Susan O'Brien, MD, Elias Jabbour, Guillermo Garcia-Manero, Alfonso Quintas-Cardama, MD, Jenny Shan, PhD, Mary Beth Rios, RN, Farhad Ravandi, MD, Stefan Faderl, MD, Tapan Kadia, Gautam Borthakur, Xuelin Huang, PhD, Hagop M. Kantarjian

Blood (2011) 118 (21): 2750.

https://doi.org/10.1182/blood.V118.21.2750.2750

Published: 2011

Journal Articles

Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes: A Multicenter Validation Study

Philippe Armand, MD, PhD, H. Joachim Deeg, Haesook T. Kim, PhD, Hun Lee, MD, Paul Armistead, MD, PhD, Marcos De Lima, MD, Vikas Gupta, MD, MRCP, MRCPath, Robert J. Soiffer, MD

Blood (2008) 112 (11): 2673.

https://doi.org/10.1182/blood.V112.11.2673.2673

Published: 2008

Journal Articles

Phase I/II Study of BI 2536, An Intravenous Polo-Like Kinase-1 (Plk-1) Inhibitor, in Elderly Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): First Results of a Multi-Center Trial

C. Müller-Tidow, MD, Gesine Bug, MD, Richard Schlenk, MD, Michael Lübbert, MD, PhD, Alwin Krämer, MD, Juergen Krauter, MD, David Nachbaur, MD, Peter Valent, MD, Tillmann Taube, MD, Gerd Munzert, MD, Kang-Hun Lee, MD, Hartmut Dohner, MD

Blood (2008) 112 (11): 2973.

https://doi.org/10.1182/blood.V112.11.2973.2973

Published: 2008

Journal Articles

Remission in Patients with Diamond Blackfan Anemia (DBA) Appears to Be Unrestricted by Phenotype or Genotype

Hun Lee, MD, Charalampos Lyssikatos, MD, Eva Atsidaftos, MA, Ellen Muir, RN, Hanna Gazda, MD, PhD, Alan H. Beggs, PhD, Jeffrey Michael Lipton, MD, PhD, Adrianna Vlachos, MD

Blood (2008) 112 (11): 3092.

https://doi.org/10.1182/blood.V112.11.3092.3092

Published: 2008

Journal Articles

Polo-Like Kinase-1 (Plk-1) Inhibitor BI 2536 Induces Mitotic Arrest and Apoptosis in Vivo: First Demonstration of Target Inhibition in the Bone Marrow of AML Patients

Kang-Hun Lee, MD, Richard F. Schlenk, MD, Gesine Bug, MD, Carsten Müller-Tidow, MD, Ralph M. Waesch, MD, David Nachbaur, MD, Peter Valent, MD, Gerd Munzert, MD, Frank Fleischer, PhD, Hartmut Dohner, MD, PhD, Pilar Garin-Chesa, PhD

Blood (2008) 112 (11): 2641.

https://doi.org/10.1182/blood.V112.11.2641.2641

Published: 2008

Journal Articles

Human Leukocyte Antigens of A33, B58 or DR7 Decrease the Treatment-Related Mortality in HLA-Matched Sibling Hematopoietic Stem Cell Transplantation in Association with Heat Shock Protein 70-Hom Polymorphisms.

Jin Won Kim, MD, So Yeon Oh, MD, Hye Jin Kim, MD, Hyeon Gyu Yi, MD, Kyung-Hun Lee, MD, Ji Young Rhee, MD, Eun-Soon Shin, PhD, Cheng Zhe Piao, PhD, Inho Kim, MD, Sung-Soo Yoon, MD, Myoung Hee Park, MD, Seonyang Park, MD, Byoung Kook Kim, MD

Blood (2007) 110 (11): 1103.

https://doi.org/10.1182/blood.V110.11.1103.1103

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Germline variants and their role in the pathogenesis of immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) in adult lymphoma patients

A Phase II, single-center, single-arm study evaluating the safety and efficacy of golidocitinib in the management of newly diagnosed PTCL (GOLDEN Study)

Mortality outcomes compared to the general population among long-term Hodgkin lymphoma survivors: A population-based analysis

Interim PET-adapted de-escalation chemotherapy regimen for advanced stage classical Hodgkin lymphoma using brentuximab vedotin, pembrolizumab, doxorubicin, and dacarbazine: Phase 2 study

Consolidation with loncastuximab tesirine for large B-cell lymphoma patients in partial response after CART: Planned interim futility analysis of a phase II trial

Impact of putative cell of origin on CD19+CAR-T outcomes in patients with large B-cell lymphoma

Impact of extranodal sites of lymphoma on clinical outcomes after CD19 CAR T cell therapy

Durable responses in the updated 2-year follow-up of patients from a single-center with Relapsed/Refractory peripheral T-cell lymphoma treated with golidocitinib

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Advanced Stage Classic Hodgkin Lymphoma: Updated Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part B)

Analysis of Factors Associated with Conversion to CR in Patients with Large B-Cell Lymphoma Achieving Day 30 PR after CAR T-Cell Therapy

Single Cell Transcriptomic Evolution and Resistance Mechanisms of BTK and BCL-2 Inhibition in Mantle Cell Lymphoma

Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience

Conditional ablation of LYVE-1+ cells unveils defensive roles of lymphatic vessels in intestine and lymph nodes

ROCK suppression promotes differentiation and expansion of endothelial cells from embryonic stem cell–derived Flk1 + mesodermal precursor cells

Improved Survival in Chronic Myeloid Leukemia (CML) Since the Introductin of Imatinib Therapy - A Single Institution Historical Experience

Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes: A Multicenter Validation Study

Phase I/II Study of BI 2536, An Intravenous Polo-Like Kinase-1 (Plk-1) Inhibitor, in Elderly Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): First Results of a Multi-Center Trial

Remission in Patients with Diamond Blackfan Anemia (DBA) Appears to Be Unrestricted by Phenotype or Genotype

Polo-Like Kinase-1 (Plk-1) Inhibitor BI 2536 Induces Mitotic Arrest and Apoptosis in Vivo: First Demonstration of Target Inhibition in the Bone Marrow of AML Patients

Human Leukocyte Antigens of A33, B58 or DR7 Decrease the Treatment-Related Mortality in HLA-Matched Sibling Hematopoietic Stem Cell Transplantation in Association with Heat Shock Protein 70-Hom Polymorphisms.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only